• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Male – Market size and forecast 2019-2024
o Female – Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by Distribution channel
o Market segments
o Comparison by Distribution channel
o Retail – Market size and forecast 2019-2024
o Online – Market size and forecast 2019-2024
o Market opportunity by Distribution channel
• Customer landscape
o Overview
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume drivers – Demand led growth
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Arkopharma Laboratories
o Church & Dwight Co. Inc.
o Dabur India Ltd.
o DCC Plc
o Doc Johnson Enterprises
o Glanbia Plc
o GNC Holdings Inc.
o Herbalife Nutrition Ltd.
o Hi-Tech Pharmaceuticals Inc.
o NOW Health Group Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2019 – 2024 ($ million)
• 14: Global market: Year-over-year growth 2019 – 2024 (%)
• 15: Five forces analysis 2019 & 2024
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2019
• 22: Product – Market share 2019-2024 (%)
• 23: Comparison by Product
• 24: Male – Market size and forecast 2019-2024 ($ million)
• 25: Male – Year-over-year growth 2019-2024 (%)
• 26: Female – Market size and forecast 2019-2024 ($ million)
• 27: Female – Year-over-year growth 2019-2024 (%)
• 28: Market opportunity by Product
• 29: Distribution channel – Market share 2019-2024 (%)
• 30: Comparison by Distribution channel
• 31: Retail – Market size and forecast 2019-2024 ($ million)
• 32: Retail – Year-over-year growth 2019-2024 (%)
• 33: Online – Market size and forecast 2019-2024 ($ million)
• 34: Online – Year-over-year growth 2019-2024 (%)
• 35: Market opportunity by Distribution channel
• 36: Customer landscape
• 37: Market share by geography 2019-2024 (%)
• 38: Geographic comparison
• 39: North America – Market size and forecast 2019-2024 ($ million)
• 40: North America – Year-over-year growth 2019-2024 (%)
• 41: Europe – Market size and forecast 2019-2024 ($ million)
• 42: Europe – Year-over-year growth 2019-2024 (%)
• 43: Asia – Market size and forecast 2019-2024 ($ million)
• 44: Asia – Year-over-year growth 2019-2024 (%)
• 45: ROW – Market size and forecast 2019-2024 ($ million)
• 46: ROW – Year-over-year growth 2019-2024 (%)
• 47: Key leading countries
• 48: Market opportunity by geography ($ million)
• 49: Impact of drivers and challenges
• 50: Vendor landscape
• 51: Landscape disruption
• 52: Industry risks
• 53: Vendors covered
• 54: Market positioning of vendors
• 55: Arkopharma Laboratories – Overview
• 56: Arkopharma Laboratories – Product and service
• 57: Arkopharma Laboratories – Key offerings
• 58: Arkopharma Laboratories – Key customers
• 59: Arkopharma Laboratories – Segment focus
• 60: Church & Dwight Co. Inc. – Overview
• 61: Church & Dwight Co. Inc. – Business segments
• 62: Church & Dwight Co. Inc. – Key offerings
• 63: Church & Dwight Co. Inc. – Key customers
• 64: Church & Dwight Co. Inc. – Segment focus
• 65: Dabur India Ltd. – Overview
• 66: Dabur India Ltd. – Business segments
• 67: Dabur India Ltd. – Key offerings
• 68: Dabur India Ltd. – Key customers
• 69: Dabur India Ltd. – Segment focus
• 70: DCC Plc – Overview
• 71: DCC Plc – Business segments
• 72: DCC Plc – Key offerings
• 73: DCC Plc – Key customers
• 74: DCC Plc – Segment focus
• 75: Doc Johnson Enterprises – Overview
• 76: Doc Johnson Enterprises – Product and service
• 77: Doc Johnson Enterprises – Key offerings
• 78: Doc Johnson Enterprises – Key customers
• 79: Doc Johnson Enterprises – Segment focus
• 80: Glanbia Plc – Overview
• 81: Glanbia Plc – Business segments
• 82: Glanbia Plc – Key offerings
• 83: Glanbia Plc – Key customers
• 84: Glanbia Plc – Segment focus
• 85: GNC Holdings Inc. – Overview
• 86: GNC Holdings Inc. – Business segments
• 87: GNC Holdings Inc. – Key offerings
• 88: GNC Holdings Inc. – Key customers
• 89: GNC Holdings Inc. – Segment focus
• 90: Herbalife Nutrition Ltd. – Overview
• 91: Herbalife Nutrition Ltd. – Business segments
• 92: Herbalife Nutrition Ltd. – Key offerings
• 93: Herbalife Nutrition Ltd. – Key customers
• 94: Herbalife Nutrition Ltd. – Segment focus
• 95: Hi-Tech Pharmaceuticals Inc. – Overview
• 96: Hi-Tech Pharmaceuticals Inc. – Product and service
• 97: Hi-Tech Pharmaceuticals Inc. – Key offerings
• 98: Hi-Tech Pharmaceuticals Inc. – Key customers
• 99: Hi-Tech Pharmaceuticals Inc. – Segment focus
• 100: NOW Health Group Inc. – Overview
• 101: NOW Health Group Inc. – Product and service
• 102: NOW Health Group Inc. – Key offerings
• 103: NOW Health Group Inc. – Key customers
• 104: NOW Health Group Inc. – Segment focus
• 105: Currency conversion rates for US$
• 106: Research Methodology
• 107: Validation techniques employed for market sizing
• 108: Information sources
• 109: List of abbreviations
【掲載企業】
Arkopharma Laboratories, Church & Dwight Co. Inc., Dabur India Ltd., DCC Plc, Doc Johnson Enterprises, Glanbia Plc, GNC Holdings Inc., Herbalife Nutrition Ltd., Hi-Tech Pharmaceuticals Inc., NOW Health Group Inc.
【免責事項】
https://www.marketreport.jp/reports-disclaimer